Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms. [electronic resource]
Producer: 20110418Description: 667-73 p. digitalISSN:- 1873-264X
- Antipsychotic Agents -- analysis
- Benzodiazepines -- analysis
- Chromatography, High Pressure Liquid
- Drug Contamination -- prevention & control
- Drug Stability
- Hot Temperature -- adverse effects
- Hydrogen-Ion Concentration
- Limit of Detection
- Olanzapine
- Oxidation-Reduction
- Quality Control
- Reproducibility of Results
- Spectrometry, Mass, Electrospray Ionization
- Tandem Mass Spectrometry
- Technology, Pharmaceutical
- Time Factors
- Ultraviolet Rays -- adverse effects
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.